Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia. more
Time Frame | MDXG | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.66% | -2.12% | -3% |
1-Month Return | 0.44% | -3.42% | -0.73% |
3-Month Return | 48.45% | -11.13% | 2.87% |
6-Month Return | 34.22% | -5.74% | 7.17% |
1-Year Return | 1.68% | 3.97% | 25.31% |
3-Year Return | 41.74% | 1.05% | 28.38% |
5-Year Return | 25.17% | 34.37% | 81.89% |
10-Year Return | -22.42% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 359.11M | 248.23M | 258.62M | 267.84M | 321.48M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":69.12,"profit":true},{"date":"2021-12-31","value":72.02,"profit":true},{"date":"2022-12-31","value":74.58,"profit":true},{"date":"2023-12-31","value":89.52,"profit":true}] |
Cost of Revenue | 36.39M | 39.33M | 43.28M | 48.32M | 54.63M | [{"date":"2019-12-31","value":66.6,"profit":true},{"date":"2020-12-31","value":71.99,"profit":true},{"date":"2021-12-31","value":79.22,"profit":true},{"date":"2022-12-31","value":88.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 322.73M | 208.90M | 215.33M | 219.53M | 266.84M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":64.73,"profit":true},{"date":"2021-12-31","value":66.72,"profit":true},{"date":"2022-12-31","value":68.02,"profit":true},{"date":"2023-12-31","value":82.68,"profit":true}] |
Gross Margin | 89.87% | 84.16% | 83.26% | 81.96% | 83.01% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":93.64,"profit":true},{"date":"2021-12-31","value":92.65,"profit":true},{"date":"2022-12-31","value":91.2,"profit":true},{"date":"2023-12-31","value":92.36,"profit":true}] |
Operating Expenses | 326.65M | 253.28M | 220.31M | 244.50M | 229.73M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":77.54,"profit":true},{"date":"2021-12-31","value":67.45,"profit":true},{"date":"2022-12-31","value":74.85,"profit":true},{"date":"2023-12-31","value":70.33,"profit":true}] |
Operating Income | (3.92M) | (44.37M) | (5.00M) | (24.97M) | 37.12M | [{"date":"2019-12-31","value":-10.57,"profit":false},{"date":"2020-12-31","value":-119.55,"profit":false},{"date":"2021-12-31","value":-13.48,"profit":false},{"date":"2022-12-31","value":-67.28,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (4.18M) | (24.09M) | (7.97M) | (10.04M) | (12.80M) | [{"date":"2019-12-31","value":-418100000,"profit":false},{"date":"2020-12-31","value":-2408600000,"profit":false},{"date":"2021-12-31","value":-796700000,"profit":false},{"date":"2022-12-31","value":-1003600000,"profit":false},{"date":"2023-12-31","value":-1279700000,"profit":false}] |
Pre-Tax Income | (3.40M) | (61.54M) | (10.04M) | (29.99M) | 30.63M | [{"date":"2019-12-31","value":-11.09,"profit":false},{"date":"2020-12-31","value":-200.9,"profit":false},{"date":"2021-12-31","value":-32.77,"profit":false},{"date":"2022-12-31","value":-97.9,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 26.58M | (12.26M) | 247.00K | 206.00K | (36.81M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-46.12,"profit":false},{"date":"2021-12-31","value":0.93,"profit":true},{"date":"2022-12-31","value":0.77,"profit":true},{"date":"2023-12-31","value":-138.46,"profit":false}] |
Income After Taxes | (29.98M) | (49.28M) | (10.29M) | (30.20M) | 67.44M | [{"date":"2019-12-31","value":-44.45,"profit":false},{"date":"2020-12-31","value":-73.08,"profit":false},{"date":"2021-12-31","value":-15.25,"profit":false},{"date":"2022-12-31","value":-44.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | (25.58M) | (49.28M) | (10.29M) | (30.20M) | 4.34M | [{"date":"2019-12-31","value":-589.81,"profit":false},{"date":"2020-12-31","value":-1136.36,"profit":false},{"date":"2021-12-31","value":-237.15,"profit":false},{"date":"2022-12-31","value":-696.26,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (29.98M) | (49.28M) | (10.29M) | (30.20M) | 67.44M | [{"date":"2019-12-31","value":-44.45,"profit":false},{"date":"2020-12-31","value":-73.08,"profit":false},{"date":"2021-12-31","value":-15.25,"profit":false},{"date":"2022-12-31","value":-44.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 0.21 | (0.05) | (0.15) | (0.33) | 0.32 | [{"date":"2019-12-31","value":66.58,"profit":true},{"date":"2020-12-31","value":-15.85,"profit":false},{"date":"2021-12-31","value":-47.56,"profit":false},{"date":"2022-12-31","value":-104.63,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
MDXG | |
---|---|
Cash Ratio | 2.12 |
Current Ratio | 4.10 |
Quick Ratio | 3.53 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
MDXG | |
---|---|
ROA (LTM) | 18.38% |
ROE (LTM) | 62.47% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
MDXG | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.26 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.74 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
MDXG | |
---|---|
Trailing PE | 15.96 |
Forward PE | 19.53 |
P/S (TTM) | 3.90 |
P/B | 7.39 |
Price/FCF | 67 |
EV/R | 3.70 |
EV/Ebitda | 18.97 |
PEG | 2.97 |
MiMedx Group Inc (MDXG) share price today is $9.1
Yes, Indians can buy shares of MiMedx Group Inc (MDXG) on Vested. To buy MiMedx Group Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MDXG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of MiMedx Group Inc (MDXG) via the Vested app. You can start investing in MiMedx Group Inc (MDXG) with a minimum investment of $1.
You can invest in shares of MiMedx Group Inc (MDXG) via Vested in three simple steps:
The 52-week high price of MiMedx Group Inc (MDXG) is $10.14. The 52-week low price of MiMedx Group Inc (MDXG) is $5.47.
The price-to-earnings (P/E) ratio of MiMedx Group Inc (MDXG) is 15.9298
The price-to-book (P/B) ratio of MiMedx Group Inc (MDXG) is 7.39
The dividend yield of MiMedx Group Inc (MDXG) is 0.00%
The market capitalization of MiMedx Group Inc (MDXG) is $1.33B
The stock symbol (or ticker) of MiMedx Group Inc is MDXG